Ching-Lung Lai Selected Research

Chronic Hepatitis B

5/2022	Effect of antiviral treatment on hepatitis B virus integration and hepatocyte clonal expansion.
1/2022	Long-term serological, virological and histological responses to RNA inhibition by ARC-520 in Chinese chronic hepatitis B patients on entecavir treatment.
6/2020	Rebound of HBV DNA after cessation of nucleos/tide analogues in chronic hepatitis B patients with undetectable covalently closed.
1/2020	RNA Interference Therapy With ARC-520 Results in Prolonged Hepatitis B Surface Antigen Response in Patients With Chronic Hepatitis B Infection.
12/2019	In Vitro and In Vivo Renoprotective Effects of Telbivudine in Chronic Hepatitis B Patients Receiving Nucleotide Analogue.
12/2019	Hepatitis B core-related antigen levels after HBeAg seroconversion is associated with the development of hepatocellular carcinoma.
10/2019	Serum Mac-2-binding protein glycosylation isomer and risk of hepatocellular carcinoma in entecavir-treated chronic hepatitis B patients.
3/2019	Serum Mac-2 binding protein glycosylation isomer level predicts hepatocellular carcinoma development in E-negative chronic hepatitis B patients.
1/2019	Plasma Fibronectin Levels Identified via Quantitative Proteomics Profiling Predicts Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B.
1/2019	Fibrosis evolution in chronic hepatitis B e antigen-negative patients across a 10-year interval.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ching-Lung Lai Research Topics

Disease

122	Chronic Hepatitis B 05/2022 - 02/2002
47	Infections 01/2020 - 02/2002
44	Hepatitis B 01/2022 - 01/2003
42	Fibrosis (Cirrhosis) 02/2022 - 03/2002
33	Hepatocellular Carcinoma (Hepatoma) 05/2022 - 03/2002
11	Hepatitis 05/2017 - 02/2002
10	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 03/2008
8	Neoplasms (Cancer) 01/2022 - 09/2002
6	Liver Diseases (Liver Disease) 11/2014 - 12/2003
5	Chronic Hepatitis C 10/2019 - 02/2002
5	Viremia 09/2015 - 02/2002
4	Liver Neoplasms (Liver Cancer) 01/2020 - 01/2013
3	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2020 - 06/2017
3	Cholangitis 01/2020 - 07/2002
3	Disease Progression 09/2015 - 08/2004
3	Reinfection 06/2013 - 02/2003
3	Chronic Hepatitis (Chronic Active Hepatitis) 12/2007 - 01/2006
2	Chronic Renal Insufficiency 10/2018 - 01/2014
2	Neoplasm Metastasis (Metastasis) 10/2017 - 09/2002
2	Coinfection 06/2017 - 01/2011
2	Inflammation (Inflammations) 01/2017 - 08/2013
2	Muscular Diseases (Myopathy) 03/2014 - 09/2010
1	Iron Overload 02/2022
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 02/2022
1	Thyroid Neoplasms (Thyroid Cancer) 01/2021
1	Non-alcoholic Fatty Liver Disease 01/2020
1	Autoimmune Hepatitis 01/2020
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2020
1	Fever (Fevers) 01/2020
1	Fatty Liver 01/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019
1	Hepatitis A (Hepatitis, Infectious) 01/2019
1	Hepatitis D 01/2019
1	Kidney Diseases (Kidney Disease) 10/2018
1	Hepatitis C 05/2018
1	Hypoalbuminemia 01/2018
1	Hypoxia (Hypoxemia) 10/2017

Drug/Important Bio-Agent (IBA)

52	DNA (Deoxyribonucleic Acid)IBA 05/2022 - 07/2002
52	Hepatitis B e AntigensIBA 01/2022 - 07/2002
41	Antiviral Agents (Antivirals)IBA 01/2020 - 02/2003
40	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2022 - 01/2003
34	Lamivudine (Epivir)FDA Link 10/2017 - 07/2002
25	entecavir FDA Link 01/2022 - 12/2002
22	NucleosidesIBA 01/2020 - 02/2003
18	NucleotidesIBA 01/2020 - 11/2004
12	AntigensIBA 01/2022 - 06/2004
12	Telbivudine FDA Link 12/2019 - 09/2004
12	Alanine Transaminase (SGPT)IBA 01/2018 - 07/2002
11	InterferonsIBA 06/2016 - 07/2002
9	Immunoglobulins (Immunoglobulin)IBA 10/2017 - 02/2003
7	Pharmaceutical PreparationsIBA 01/2020 - 01/2006
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2008
6	hepatitis B hyperimmune globulinIBA 12/2015 - 02/2003
6	adefovir dipivoxil (Hepsera)FDA Link 12/2007 - 12/2003
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2013
5	adefovirIBA 12/2019 - 12/2007
5	Tenofovir (Viread)FDA Link 12/2019 - 01/2011
5	nasIBA 01/2019 - 01/2007
5	Circular DNAIBA 12/2017 - 10/2006
5	Ribavirin (Virazole)FDA LinkGeneric 06/2017 - 04/2003
4	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022 - 03/2002
4	BilirubinIBA 01/2011 - 03/2002
3	ARC-520IBA 01/2022 - 07/2017
3	((1- ((2- amino- 9H- purin- 9- yl)methyl)cyclopropyl)oxy)methylphosphonic acid dipivoxylIBA 01/2018 - 06/2014
3	Messenger RNA (mRNA)IBA 07/2017 - 10/2006
3	HLA-DP Antigens (HLA-DP)IBA 03/2014 - 01/2013
3	Interferon-alpha (Interferon Alfa)IBA 01/2013 - 06/2003
3	AlbuminsIBA 01/2011 - 08/2003
3	alpha-Fetoproteins (alpha-Fetoprotein)IBA 07/2008 - 09/2002
2	RNA (Ribonucleic Acid)IBA 01/2022 - 06/2020
2	teleocalcinIBA 01/2022 - 10/2017
2	Viral DNAIBA 06/2020 - 01/2017
2	Reverse Transcriptase InhibitorsIBA 01/2020 - 09/2015
2	SofosbuvirIBA 10/2019 - 12/2015
2	velpatasvirIBA 10/2019 - 12/2015
2	Carrier Proteins (Binding Protein)IBA 03/2019 - 07/2017
2	Surface Antigens (Surface Antigen)IBA 01/2018 - 01/2012
2	Transaminases (Aminotransferases)IBA 11/2017 - 01/2006
2	Creatine Kinase (Creatine Phosphokinase)IBA 03/2014 - 09/2010
2	VaccinesIBA 10/2012 - 12/2008
1	Familial apoceruloplasmin deficiencyIBA 02/2022
1	SilverIBA 02/2022
1	Phosphotransferases (Kinase)IBA 01/2021
1	lenvatinibIBA 01/2021
1	Hepatitis B Core AntigensIBA 01/2019
1	Fibronectins (Fibronectin)IBA 01/2019
1	AntibodiesIBA 01/2019
1	Protease Inhibitors (Protease Inhibitor)IBA 05/2018
1	lipoarabinomannan (LAM)IBA 10/2017
1	wisteria lectinIBA 07/2017

Therapy/Procedure

56	Therapeutics 01/2021 - 02/2002
20	Liver Transplantation 11/2017 - 01/2003
3	Duration of Therapy 05/2016 - 08/2008
2	Aftercare (After-Treatment) 01/2018 - 11/2017
2	Drug Therapy (Chemotherapy) 05/2016 - 11/2014
2	Withholding Treatment 09/2015 - 04/2015
2	Blood Transfusion (Blood Transfusions) 03/2011 - 09/2010
2	Oral Administration 05/2009 - 03/2006
2	Endoscopic Sphincterotomy 10/2003 - 07/2002
1	Contraindications 05/2018